Latest News & Features
Americas
The US Department of Commerce (DOC) has said that there are “shortcomings” in China’s IP rights when it comes to the country’s pharmaceutical sector. 15 January 2018
Europe
Regeneron Pharmaceuticals has formed a consortium with five other companies to fund the generation of exome sequence data from 500,000 volunteers in the UK. 12 January 2018
Biotechnology
Israel-based Teva Pharmaceuticals has signed a global licence agreement with Alder BioPharmaceuticals. 11 January 2018
Americas
Allergan and the Native American tribe that acquired Allergan’s patents for Restasis have told the US Court of Appeals for the Federal Circuit that patents covering the dry eye treatment are valid. 11 January 2018
Americas
The US Court of Appeals for the Federal Circuit has confirmed that claims within a patent relating to genetically modified soybeans are invalid due to anticipation and obviousness. 11 January 2018
Big Pharma
Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion). 10 January 2018
Asia-Pacific
Southeast Asia-based law firm Tilleke & Gibbins has appointed an IP enforcement specialist to partner. 10 January 2018
Big Pharma
UK-headquartered AstraZeneca and Japanese pharmaceutical company Eisai have urged the UK to remain a member of the European Medicines Agency. 9 January 2018
Americas
Global biopharmaceutical company Celgene Corporation, headquartered in New Jersey, has filed a claim against oncology company Beacon Pharmaceuticals, situated in Bangladesh, for trademark infringement. 9 January 2018
Americas
Celgene Corporation is to acquire Impact Biomedicines in the first quarter of 2018. 9 January 2018